IQV Pengajuan SEC - IQVIA Holdings Inc.- Laporan Tahunan, Pernyataan Kuasa, Prospektus

Mga Batayang Estadistika

LEI	549300W3R20NM4KQPH86
CIK	1478242

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to IQVIA Holdings Inc.

SEC Filings (Chronological Order)

Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.

September 2, 2025	EX-99.1	IQVIA Announces CFO Transition in Early 2026 Ron Bruehlman to become Senior Advisor to CEO; Michael Fedock Named as New CFO EX-99.1 Exhibit 99.1 News Release Contact: Kerri Joseph, IQVIA Investor Relations ([email protected]) +1.973.541.3558 Alissa Maupin, IQVIA Media Relations ([email protected]) +1.919.923.6785 IQVIA Announces CFO Transition in Early 2026 Ron Bruehlman to become Senior Advisor to CEO; Michael Fedock Named as New CFO RESEARCH TRIANGLE PARK, N.C. — (BUSINESS WIRE) — IQVIA Holdings Inc. (“IQ
September 2, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 2, 2025 IQVIA HOLDINGS UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 2, 2025 IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation) (Commission F
July 22, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-35907 IQVIA HO
July 22, 2025	EX-22.1	List of Subsidiary Guarantors and Affiliates who Collateralize the Company’s Securities. Exhibit 22.1 Subsidiary Guarantors and Issuers of Guaranteed Securities The following entities were, as of June 30, 2025, guarantors of IQVIA Inc.’s 5.700% Senior Secured Notes due 2028 and 6.250% Senior Secured Notes due 2029. Entity Role IQVIA Inc. Issuer IQVIA Holdings Inc. Guarantor Benefit Holding, Inc. Guarantor BuzzeoPDMA LLC Guarantor Data Niche Associates, Inc. Guarantor IMS Software Serv
July 22, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 22, 2025 IQVIA HOLDINGS INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 22, 2025 IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation) (Commission File
July 22, 2025	EX-99.1	IQVIA Reports Second-Quarter 2025 Results Exhibit 99.1 IQVIA Reports Second-Quarter 2025 Results •Revenue of $4,017 million, up 5.3 percent year-over-year •GAAP Net Income of $266 million, Adjusted EBITDA of $910 million •GAAP Diluted Earnings per Share of $1.54, Adjusted Diluted Earnings per Share of $2.81 •R&D Solutions quarterly bookings of $2.5 billion, representing a book-to-bill ratio of 1.12x •R&D Solutions contracted backlog of $3
June 4, 2025	8-K	Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 4, 2025 IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation) (Commission File N
June 4, 2025	EX-4.1	Indenture, dated June 4, 2025, among IQVIA Inc., as Issuer, U.S. Bank Trust Company, National Association, as trustee of the Notes and certain subsidiaries of the Issuer as guarantors. EX-4.1 Exhibit 4.1 INDENTURE Dated as of June 4, 2025 among IQVIA Inc., as Issuer, the Guarantors party hereto, U.S. Bank Trust Company, National Association, as Trustee 6.250% SENIOR NOTES DUE 2032 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS AND INCORPORATION BY REFERENCE SECTION 1.01. Definitions 1 SECTION 1.02. Other Definitions 33 SECTION 1.03. Rules of Construction 33 SECTION 1.04. Acts of H
June 2, 2025	EX-99.1	IQVIA Announces Offering of Senior Notes Exhibit 99.1 IQVIA Announces Offering of Senior Notes June 2, 2025 RESEARCH TRIANGLE PARK, N.C. – IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly-owned subsidiary, IQVIA Inc. (the “Issuer”), intends to raise $2,000,000,000 through an offering of senior notes due 2032 (the “Notes”). The proceeds from the Notes offering will be used to repay existing borrowings under the Iss
June 2, 2025	EX-99.2	IQVIA Announces Pricing of Senior Notes Exhibit 99.2 IQVIA Announces Pricing of Senior Notes June 2, 2025 RESEARCH TRIANGLE PARK, N.C. – IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly-owned subsidiary, IQVIA Inc. (the “Issuer”), priced an offering of $2,000,000,000 in aggregate principal amount of senior notes due 2032 (the “Notes”). The proceeds from the Notes offering will be used to repay existing borrowings
June 2, 2025	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 2, 2025 IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation) (Commission File N
May 6, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-35907 IQVIA H
May 6, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2025 IQVIA HOLDINGS INC. ( UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2025 IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation) (Commission File Nu
May 6, 2025	EX-22.1	List of Subsidiary Guarantors and Affiliates who Collateralize the Company’s Securitie Exhibit 22.1 Subsidiary Guarantors and Issuers of Guaranteed Securities The following entities were, as of March 31, 2025, guarantors of IQVIA Inc.’s 5.700% Senior Secured Notes due 2028 and 6.250% Senior Secured Notes due 2029. Entity Role IQVIA Inc. Issuer IQVIA Holdings Inc. Guarantor Benefit Holding, Inc. Guarantor BuzzeoPDMA LLC Guarantor Data Niche Associates, Inc. Guarantor IMS Software Ser
May 6, 2025	EX-99.1	IQVIA Reports First-Quarter 2025 Results Exhibit 99.1 IQVIA Reports First-Quarter 2025 Results •Revenue of $3,829 million •GAAP Net Income of $249 million, Adjusted EBITDA of $883 million •GAAP Diluted Earnings per Share of $1.40, Adjusted Diluted Earnings per Share of $2.70 •R&D Solutions quarterly bookings of $2.1 billion, resulting in trailing-twelve-month bookings of $9.7 billion and a trailing-twelve-month book-to-bill ratio of 1.14
April 24, 2025	EX-3.1	Amended and Restated Certificate of Incorporation of IQVIA Holdings Inc., effective April 24, 2025. EX-3.1 Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF IQVIA HOLDINGS INC. (Under Sections 242 and 245 of the Delaware General Corporation Law) IQVIA Holdings Inc., a corporation organized and existing under the laws of the State of Delaware, as amended (the “Corporation”), does hereby certify as follows: FIRST. The Corporation filed its original certificate of incorporation with
April 24, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 24, 2025 IQVIA HOLDINGS INC UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 24, 2025 IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation) (Commission File
March 10, 2025	8-K	Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 10, 2025 IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation) (Commission File
March 10, 2025	EX-10.1	Amendment No. 4 to Fifth Amended and Restated Credit Agreement, dated March 10, 2025, among IQVIA Inc., IQVIA Holdings Inc., IQVIA RDS Inc., the other guarantors party thereto, Bank of America, N.A. as administrative agent and as collateral agent, and the Lenders party thereto. Exhibit 10.1 Execution Version AMENDMENT NO. 4 TO FIFTH AMENDED AND RESTATED CREDIT AGREEMENT AMENDMENT NO. 4, dated as of March 10, 2025 (this “Amendment”), among IQVIA Inc., a Delaware corporation (the “Parent Borrower”), IQVIA RDS Inc., a North Carolina corporation and a subsidiary of the Parent Borrower (the “U.S. Borrower”), IQVIA Holdings Inc., a Delaware corporation (“Holdings”), the other
February 28, 2025	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No.
February 28, 2025	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No.
February 18, 2025	PRE 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No.
February 13, 2025	EX-22.1	List of Subsidiary Guarantors and Affiliates who Collateralize the Company’s Securities Exhibit 22.1 Subsidiary Guarantors and Issuers of Guaranteed Securities The following entities were, as of December 31, 2024, guarantors of IQVIA Inc.’s 5.700% Senior Secured Notes due 2028 and 6.250% Senior Secured Notes due 2029. Entity Role IQVIA Inc. Issuer IQVIA Holdings Inc. Guarantor Benefit Holding, Inc. Guarantor BuzzeoPDMA LLC Guarantor Data Niche Associates, Inc. Guarantor IMS Software
February 13, 2025	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-35907 IQVIA HOLDIN
February 13, 2025	EX-21.1	List of Subsidiaries of IQVIA Holdings Inc. Exhibit 21.1 IQVIA Holdings Inc. Subsidiary Listing - as of 12/31/2024 Subsidiary Jurisdiction or State of Organization 159 Solutions, LLC California 159 Technology Solutions Private Ltd India 1HQ (NL) B.V. Netherlands 1HQ Limited United Kingdom 1HQ Singapore Pte Ltd Singapore 1HQ USA, LLC NY Accurate Health Auditing and Consulting Société Anonyme of Coordination Organisation & Health Investments
February 13, 2025	EX-10.36	Employment Agreement between IQVIA AG and Bhavik Patel, effective as of August 7, 2018, as amended on August 9, 2022 and August 1, 2023. Exhibit 10.36 [REDACTED] Bhavik Patel [REDACTED] 7 August 2018 Contract of employment These are the terms and conditions of your contract of employment as required by section 1 of the Employment Rights Act 1996. Commencement of employment Your employer is IQVIA AG (in UK), (Company or we). Your employment with the Company under this contract of employment started on 12 October 2005 and your contin
February 13, 2025	EX-19.1	Securities Trading Policy Exhibit 19.1 IQVIA Securities Trading Policy (amended June 2023) 1.PURPOSE This Securities Trading Policy (the “Policy”) sets forth IQVIA Holdings Inc.’s (“IQVIA” or, the “Company”) commitment to promote compliance with federal, state, and foreign securities laws that prohibit trading securities with the knowledge of material nonpublic information (insider trading), places restrictions on certain
February 6, 2025	EX-99.1	IQVIA Reports Fourth-Quarter and Full-Year 2024 Results; Reaffirms Full-Year 2025 Guidance Exhibit 99.1 IQVIA Reports Fourth-Quarter and Full-Year 2024 Results; Reaffirms Full-Year 2025 Guidance •Revenue of $3,958 million for the fourth quarter, $15,405 million for the full year •GAAP Net Income of $437 million for the fourth quarter, $1,373 million for the full year •Adjusted EBITDA of $996 million for the fourth quarter, $3,684 million for the full year •GAAP Diluted Earnings per Shar
February 6, 2025	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 6, 2025 IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation) (Commission Fi
October 31, 2024	EX-22.1	List of Subsidiary Guarantors and Affiliates who Collateralize the Company’s Securities Exhibit 22.1 Subsidiary Guarantors and Issuers of Guaranteed Securities The following entities were, as of September 30, 2024, guarantors of IQVIA Inc.’s 5.700% Senior Secured Notes due 2028 and 6.250% Senior Secured Notes due 2029. Entity Role IQVIA Inc. Issuer IQVIA Holdings Inc. Guarantor Benefit Holding, Inc. Guarantor BuzzeoPDMA LLC Guarantor Cognitive Clinical Trials, LLC Guarantor Data Nich
October 31, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 31, 2024 IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation) (Commission Fi
October 31, 2024	EX-99.1	IQVIA Reports Third-Quarter 2024 Results and Announces Investor Day Exhibit 99.1 IQVIA Reports Third-Quarter 2024 Results and Announces Investor Day •Revenue of $3,896 million •GAAP Net Income of $285 million, Adjusted EBITDA of $939 million •GAAP Diluted Earnings per Share of $1.55, Adjusted Diluted Earnings per Share of $2.84 •R&D Solutions quarterly bookings of $2.3 billion, resulting in trailing-twelve-month bookings of $10.4 billion and a trailing-twelve-mont
October 31, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-35907 IQV
August 15, 2024	SC 13G	IQV / IQVIA Holdings Inc. / GIC Private Ltd - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ) * IQVIA HOLDINGS INC. (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 46266C105 (CUSIP Number) August 13, 2024 (Date of the Event Which Requires Filing of this Statement) Check the appropriate box to designate the ru
July 22, 2024	EX-4.1	Supplemental Indenture, dated as of June 27, 2024, among the subsidiary guarantors named on the signature pages thereto and U.S. Bank Trust Company, National Association, as trustee of the 5.700% Senior Secured Notes due 2028. Exhibit 4.1 Execution Version SUPPLEMENTAL INDENTURE TO BE DELIVERED BY SUBSEQUENT GUARANTORS Supplemental Indenture (this “Supplemental Indenture”), dated as of June 27, 2024, among Rules-Based Medicine Inc., a Delaware corporation, Lasso Marketing, Inc., a Delaware corporation and Cognitive Clinical Trials, LLC, a Delaware limited liability company (each a “Guaranteeing Subsidiary”), a subsidiar
July 22, 2024	EX-22.1	List of Subsidiary Guarantors and Affiliates who Collateralize the Company’s Securities Exhibit 22.1 Subsidiary Guarantors and Issuers of Guaranteed Securities The following entities were, as of June 30, 2024, guarantors of IQVIA Inc.’s 5.700% Senior Secured Notes due 2028 and 6.250% Senior Secured Notes due 2029. Entity Role IQVIA Inc. Issuer IQVIA Holdings Inc. Guarantor Benefit Holding, Inc. Guarantor BuzzeoPDMA LLC Guarantor Cognitive Clinical Trials, LLC Guarantor Data Niche Ass
July 22, 2024	EX-99.1	IQVIA Reports Second-Quarter 2024 Results Exhibit 99.1 IQVIA Reports Second-Quarter 2024 Results •Revenue of $3,814 million •GAAP Net Income of $363 million, Adjusted EBITDA of $887 million •GAAP Diluted Earnings per Share of $1.97, Adjusted Diluted Earnings per Share of $2.64 •R&D Solutions quarterly bookings of $2.7 billion, representing a book-to-bill ratio of 1.27x •R&D Solutions contracted backlog of $30.6 billion, up 7.7 percent rep
July 22, 2024	EX-4.2	Supplemental Indenture, dated as of June 27, 2024, among the subsidiary guarantors named on the signature pages thereto and U.S. Bank Trust Company, National Association, as trustee of the 6.250% Senior Secured Notes due 2029. Exhibit 4.2 Execution Version SUPPLEMENTAL INDENTURE TO BE DELIVERED BY SUBSEQUENT GUARANTORS Supplemental Indenture (this “Supplemental Indenture”), dated as of June 27, 2024, among Rules-Based Medicine Inc., a Delaware corporation, Lasso Marketing, Inc., a Delaware corporation, and Cognitive Clinical Trials, LLC, a Delaware limited liability company (each a “Guaranteeing Subsidiary”), each a sub
July 22, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-35907 IQVIA HO
July 22, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 22, 2024 IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation) (Commission File
May 10, 2024	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 10, 2024 (May 6, 2024) IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation) (Com
May 2, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 2, 2024 IQVIA HOLDINGS INC. ( UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 2, 2024 IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation) (Commission File Nu
May 2, 2024	EX-99.1	IQVIA Reports First-Quarter 2024 Results Exhibit 99.1 IQVIA Reports First-Quarter 2024 Results • Revenue of $3,737 million • GAAP Net Income of $288 million, Adjusted EBITDA of $862 million • GAAP Diluted Earnings per Share of $1.56, Adjusted Diluted Earnings per Share of $2.54 • R&D Solutions quarterly bookings of $2.6 billion, representing a book-to-bill ratio of 1.23x • R&D Solutions contracted backlog of $30.1 billion, up 7.9 percent
May 2, 2024	EX-22.1	List of Subsidiary Guarantors and Affiliates who Collateralize the Company’s Securities Exhibit 22.1 Subsidiary Guarantors and Issuers of Guaranteed Securities The following entities were, as of March 31, 2024, guarantors of IQVIA Inc.’s 5.700% Senior Secured Notes due 2028 and 6.250% Senior Secured Notes due 2029. Entity Role IQVIA Inc. Issuer IQVIA Holdings Inc. Guarantor Benefit Holding, Inc. Guarantor BuzzeoPDMA LLC Guarantor Data Niche Associates, Inc. Guarantor IMS Software Ser
May 2, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-35907 IQVIA H
April 17, 2024	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 17, 2024 (April 16, 2024) IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation)
February 23, 2024	DEF 14A	NOTICE OF 2024 ANNUAL MEETING OF STOCKHOLDERS Message from our Lead Independent Director Message from our CEO Proxy Statement Summary PROPOSAL NO. 1 Election of Directors Corporate Governance Director Compensation PROPOSAL NO. 2 Advisory Non-Binding UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No.
February 23, 2024	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No.
February 23, 2024	DEF 14A	COURTESY PDF OF PROXY STATEMENT 1 NOTICE O OF 2024 ANNUAL MEETING OF STOCKHOLDERS Dear Stockholder: You are cordially invited to attend the 2024 Annual Meeting of Stockholders of IQVIA Holdings Inc.
February 15, 2024	EX-10.28	IQVIA Elective Deferred Compensation Plan, as amended and restated. Exhibit 10.28 IQVIA ELECTIVE DEFERRED COMPENSATION PLAN (POST 409A) (Amended and Restated Effective January 1, 2018) The purpose of this IQVIA Elective Deferred Compensation Plan (Post-409A) (the “Plan”) is to further the success of IQVIA Inc. (the “Company”) and its affiliates by providing deferred compensation for a select group of management and highly compensated employees, thereby giving such
February 15, 2024	EX-4.1	Description of the Company's Securities Exhibit 4.1 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 IQVIA Holdings Inc. (“IQVIA”, the “Registrant”, the “Company”, “us”, “we”, or “our”) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), our common stock, par value $0.01 per share (the “common s
February 15, 2024	EX-21.1	List of Subsidiaries of IQVIA Holdings Inc. Exhibit 21.1 IQVIA Holdings Inc. Subsidiary Listing - as of 12/31/2023 Subsidiary Jurisdiction or State of Organization 159 Solutions, LLC California 159 Technology Solutions Private Ltd India AECIO IT Solutions India Private Ltd. India AHM Global Services, LLC New Jersey AIT Bioscience LLC Indiana Albatross Financial Solutions Limited United Kingdom ALIMED Egeszsegugyi Szolgaltato Kft. Hungary Al
February 15, 2024	EX-10.29	IQVIA Holdings Inc. Non-Employee Director Deferral Plan, effective January 1, 2017 (amended November 9, 2023). Exhibit 10.29 IQVIA HOLDINGS INC. Non-Employee Director Deferral Plan Effective January 1, 2017 (Amended November 9, 2023) 1. Purpose of the Plan; Status as Sub-Plan. The purpose of this Non-Employee Director Deferral Plan (the “Plan”) is to provide a convenient means for non-employee directors to increase their proprietary interest in IQVIA Holdings Inc., a Delaware corporation (the “Company”), i
February 15, 2024	EX-10.27	IQVIA Savings Equalization Plan, effective January 1, 2018. Exhibit 10.27 IQVIA INC. IQVIA SAVINGS EQUALIZATION PLAN Effective January 1, 2018 I. Purpose of the Plan The purpose of the IQVIA Savings Equalization Plan (the “Plan”) is to provide a means of equalizing the benefits of those employees participating in the IQVIA 401(k) Plan (the “401(k) Plan”) whose matching contributions under the 401(k) Plan are or will be limited by the application of Section
February 15, 2024	EX-10.19	IMS Health Incorporated Retirement Plan, as amended and restated effective January 1, 2020 Exhibit 10.19 IMS HEALTH INCORPORATED RETIREMENT PLAN As Amended and Restated Effective January 1, 2020 (except as otherwise provided herein) TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS 1 1.1 “Accrued Benefit” 1 1.2 “Actuarial Equivalent Value” 1 1.3 “Affiliated Employer” 2 1.4 “Age” 2 1.5 “Average Final Compensation” 2 1.6 “Beneficiary” 3 1.7 “Benefit Commencement Date” 3 1.8 “Board” 3 1.9 “Code
February 15, 2024	EX-10.35	Letter Agreement between the Company and W. Richard Staub, effective on Exhibit 10.35 Name: W. Richard Staub, III We are very pleased to extend this offer for the role of President, Research & Development Solutions. Except as otherwise provided herein, this Offer Letter (the “Offer Letter”) supersedes any terms of your November 30, 2016 Offer Letter (the “2016 Offer Letter”) that conflict with the terms of this Offer Letter. A copy of your November 30, 2016 Offer Lett
February 15, 2024	EX-97.1	Restatement Recovery Policy, dated November 9, 2023. Exhibit 97.1 RESTATEMENT RECOVERY POLICY Section 1. Introduction. The board of directors (the “Board”) of IQVIA Holdings Inc. (the “Company”) has adopted this policy (the “Policy”) to provide for the recovery by the Company, in the event of a Recovery Trigger (as defined below), of certain incentive-based compensation received by certain current and former executive officers, as further specified
February 15, 2024	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-35907 IQVIA HOLDIN
February 15, 2024	EX-10.9	Confidentiality and Restrictive Covenants Exhibit 10.9 CONFIDENTIALITY AND RESTRICTIVE COVENANTS AGREEMENT (IQVIA US Version – June 2023) By entering into this Confidentiality and Restrictive Covenants Agreement (this “Agreement”), I acknowledge that IQVIA Holdings Inc., a Delaware corporation (“IQVIA”), and its Subsidiaries (as defined below) (collectively, the “Company”) has an interest in protecting its confidential information and tha
February 15, 2024	EX-10.10	Work Product Assignment Exhibit 10.10 WORK PRODUCT ASSIGNMENT AGREEMENT (IQVIA US Version – February 2019) By entering into this Work Product Assignment Agreement (this “Agreement”), I acknowledge that IQVIA Holdings Inc., a Delaware corporation (“IQVIA”), and its Subsidiaries (as defined below) (collectively, the “Company”) has an interest in protecting the ownership of Intellectual Property Rights (as defined below). T
February 14, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 14, 2024 IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation) (Commission F
February 14, 2024	EX-99.1	IQVIA Reports Fourth-Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance Exhibit 99.1 IQVIA Reports Fourth-Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance Revenue of $3,868 million for the fourth quarter, $14,984 million for the full year GAAP Net Income of $469 million for the fourth quarter, $1,358 million for the full year Adjusted EBITDA of $966 million for the fourth quarter, $3,569 million for the full year GAAP Diluted Earnings per Share of $2
February 14, 2024	SC 13G	IQV / IQVIA Holdings Inc. / HARRIS ASSOCIATES L P Passive Investment SC 13G 1 formsc13g-02142024090247.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 IQVIA Holdings Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 46266C105 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to
February 13, 2024	SC 13G/A	IQV / IQVIA Holdings Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv01227-iqviaholdingsinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 10)* Name of issuer: IQVIA Holdings Inc Title of Class of Securities: Common Stock CUSIP Number: 46266C105 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designa
January 25, 2024	424B3	IQVIA INC. OFFER TO EXCHANGE $750,000,000 aggregate principal amount of 5.700% Senior Secured Notes due 2028, the issuance of which has been registered under the Securities Act, as amended, for any and all of its outstanding 5.700% Senior Secured Not Table of Contents Filed Pursuant to 424(b)(3) Registration No. 333-276404 PROSPECTUS IQVIA INC. OFFER TO EXCHANGE $750,000,000 aggregate principal amount of 5.700% Senior Secured Notes due 2028, the issuance of which has been registered under the Securities Act, as amended, for any and all of its outstanding 5.700% Senior Secured Notes due 2028, and $1,250,000,000 aggregate principal amount of 6.2
January 18, 2024	S-4/A	As filed with the Securities and Exchange Commission on January 18, 2024 Table of Contents As filed with the Securities and Exchange Commission on January 18, 2024 Registration No.
January 18, 2024	EX-FILING FEES	Filing Fee Table. Exhibit 107 Calculation of Filing Fee Tables Form S-4 (Form Type) IQVIA Holdings Inc.
January 18, 2024	CORRESP	January 18, 2024 January 18, 2024 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street, N.
January 18, 2024	EX-99.1	Letter of Transmittal. Exhibit 99.1 IQVIA INC. LETTER OF TRANSMITTAL OFFER TO EXCHANGE $750,000,000 AGGREGATE PRINCIPAL AMOUNT OF ITS 5.700% SENIOR SECURED NOTES DUE 2028 AND $1,250,000,000 AGGREGATE PRINCIPAL AMOUNT OF ITS 6.250% SENIOR SECURED NOTES DUE 2029, THE ISSUANCE OF WHICH HAS BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, FOR ALL OF ITS OUTSTANDING 5.700% SENIOR SECURED NOTES DUE 2028 AND ALL O
January 5, 2024	EX-3.59	Articles of Organization of Targeted Molecular Diagnostics, LLC, as amended EX-3.59 Exhibit 3.59 Form LLC-5.5 Illinois This space for use by Secretary of State December 2003 Limited Liability Company Act FILE DATE 1/22/2004 JESSE WHITE SECRETARY OF STATE Jesse White Articles of Organization Secretary of State This space for use by Secretary of State Date 1/22/2004 Assigned File # 0109 698 2 Filing Fee $500.00 Approved: PMM Department of Business Services Limited Liability
January 5, 2024	EX-3.69	Certificate of Formation of Q Squared Solutions Holdings LLC, as amended EX-3.69 Exhibit 3.69 CLINICAL LAB SERVICES, LLC CERTIFICATE OF FORMATION This Certificate of Formation is being executed on June 8, 2015 for the purpose of forming a limited liability company pursuant to the Delaware Limited Liability Company Act. The undersigned, being duly authorized to execute and file this Certificate of Formation, does hereby certify as follows: l. The name of the limited lia
January 5, 2024	EX-3.64	By-laws of VCG&A, Inc. EX-3.64 Exhibit 3.64 VCG&A, INC. BY-LAWS ARTICLE I - STOCKHOLDERS 1. Place of Meetings. All meetings of the stockholders shall be held either at the principal office of the Corporation or at such other place within the United States as is determined by the Board of Directors and stated in the notice of the meeting. 2. Annual Meetings. The annual meeting of the stockholders entitled to vote shall b
January 5, 2024	EX-3.13	Articles of Incorporation of Innovex Merger Corp., as amended EX-3.13 Exhibit 3.13 Articles of Incorporation of Innovex Merger Corp. The undersigned does hereby submit these Articles of Incorporation for the purpose of forming a business corporation under and by virtue of the laws of the State of North Carolina: 1. The name of the corporation is Innovex Merger Corp. 2. The corporation is authorized to issue two classes of capital stock to be designated “Comm
January 5, 2024	EX-3.63	Articles of Organization of VCG&A, Inc., as amended EX-3.63 Exhibit 3.63 The Commonwealth of Massachusetts William Francis Galvin Secretary of the Commonwealth One Ashburton Place, Boston, Massachusetts 02108-1512 ARTICLES OF ORGANIZATION (General Laws, Chapter 156B) ARTICLE I The exact name of the corporation is: VCG&A, Inc. ARTICIE II The purpose of the corporation is to engage in the following business activities: To provide consulting services
January 5, 2024	EX-3.46	Second Amended and Restated Limited Liability Company Agreement of IQVIA RDS Latin America LLC EX-3.46 Exhibit 3.46 SECOND AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT among IQVIA RDS LATIN AMERICA LLC and THE MEMBERS NAMED HEREIN dated as of November 10, 2023 TABLE OF CONTENTS Page ARTICLE I FORMATION OF THE COMPANY 1 1.1 Formation 1 1.2 Name 1 1.3 Registered Office and Registered Agent 1 1.4 Principal Place of Business 1 1.5 Purposes and Powers 1 1.6 Term 1 1.7 Nature of Membe
January 5, 2024	EX-3.26	By-laws of IQVIA Commercial India Holdings Corp. EX-3.26 Exhibit 3.26 Now known as IQVIA Commercial India Holdings Corp. BY-LAWS OF COGNIZANT INDIA HOLDING CORPORATION ARTICLE I SHAREOWNERS Section 1. The annual meeting of the shareowners of the corporation for the purpose of electing directors and for the transaction of such other business as may properly be brought before the meeting shall be held on the third Wednesday in April of each year,
January 5, 2024	EX-3.67	Articles of Organization of Q Squared Solutions LLC, as amended EX-3.67 Exhibit 3.67 State of North Carolina Department of the Secretary of State ARTICLES OF ORGANIZATION INCLUDING ARTICLES OF CONVERSION Pursuant to §§ 57C-2-21, 57C-9A-0l and 57C-9A-03 of the General Statutes of North Carolina, the undersigned converting business entity does hereby submit these Articles of Organization Including Articles of Conversion for the purpose of forming a limited liabi
January 5, 2024	EX-3.71	Articles of Incorporation of QCare Site Services, Inc., as amended EX-3.71 Exhibit 3.71 QUINTILES FEDERATED SERVICES, INC. ARTICLES OF INCORPORATION The undersigned does hereby submit these Articles of Incorporation for the purpose of forming a business corporation under and by virtue of the laws of the State of North Carolina: 1. The name of the corporation is Quintiles Federated Services, Inc. 2. The corporation shall have authority to issue Ten Thousand (10,00
January 5, 2024	EX-3.9	Articles of Incorporation of Data Niche Associates, Inc., as amended EX-3.9 Exhibit 3.9 ARTICLES OF INCORPORATION OF DATA NICHE ASSOCIATES, INC. TO: Secretary of State State of Illinois Corporation Department Springfield, Illinois 62756 I, the incorporator, being a person, for the purpose of forming a corporation under The Business Corporation Act of 1983 (Ill. Rev. Stat., ch. 32, par. 1.01 et seq.), do hereby adopt the following Articles of Incorporation: AR
January 5, 2024	EX-3.65	Certificate of Incorporation of VCG-BIO, INC., as amended EX-3.65 Exhibit 3.65 CERTIFICATE OF INCORPORATION OF VCG-BIO, INC. FIRST: The name of the Corporation is: VCG-BIO, INC. SECOND: The address of the Corporation’s registered office in the State of Delaware is 1220 N. Market Street, Suite 850, Wilmington, Delaware 19801 in the County of New Castle. The name of its registered agent at such address is Delaware Corporate Services Inc. THIRD: The nature
January 5, 2024	EX-3.30	Bylaws of IQVIA Government Solutions Inc. EX-3.30 Exhibit 3.30 BY-LAWS OF IMS Government Solutions, Inc. Section 1. LAW, CERTIFICATE AND BY-LAWS 1.1 These by-laws are subject to the certificate of incorporation (the “Certificate”) of IMS Governmental Solutions, inc. (the “Corporation”). In these by-laws, references to law, the Certificate and by-laws mean the law, the provisions of the Certificate and the by-laws as from time to time in e
January 5, 2024	EX-3.43	Articles of Incorporation of IQVIA RDS Inc., as amended EX-3.43 Exhibit 3.43 ARTICLES OF INCORPORATION OF QUINTILES, INC. The undersigned, being of the age of eighteen years or more, does hereby make and acknowledge these Articles of Incorporation for the purpose of forming a business corporation under and by virtue of the laws of the State of North Carolina: 1. The name of the corporation is Quintiles, Inc. 2. The period of duration of the corporation
January 5, 2024	EX-3.4	Amended and Restated By-laws of IQVIA Inc. EX-3.4 Exhibit 3.4 AMENDED AND RESTATED BY-LAWS OF IQVIA INC. (F.K.A. QUINTILES IMS INCORPORATED: 10/3/2016 TO 11/6/2017) (F.K.A. IMS HEALTH INCORPORATED: PRIOR TO 10/3/2016) (as amended through October 25, 2011) Section 1. LAW, CERTIFICATE OF INCORPORATION AND BY-LAWS 1.1. These by-laws are subject to the certificate of incorporation of the corporation. In these by-laws, references to law, the ce
January 5, 2024	EX-3.8	LLC Agreement of BuzzeoPDMA LLC EX-3.8 Exhibit 3.8 LIMITED LIABILITY COMPANY AGREEMENT OF BUZZEOPDMA LLC This Limited Liability Company Agreement (the “Agreement”) of BuzzeoPDMA LLC is entered into as of the 26th day of October, 2010 by Cegedim Inc., as the sole member of the limited liability company (the “Member”). The Member hereby forms a limited liability company pursuant to an in accordance with the Delaware Limited Liabil
January 5, 2024	EX-3.22	Amended and Restated By-Laws of IMS Chinametrik Inc. EX-3.22 Exhibit 3.22 Now known as IQVIA Chinametrik Inc. AMENDED AND RESTATED BY-LAWS OF IMS CHINAMETRIK INCORPORATED ARTICLE I SHAREOWNERS Section 1. The annual meeting of the shareowners of the corporation for the purpose of electing directors and for the transaction of such other business as may properly be brought before the meeting shall be held on the third Wednesday in April of each year, i
January 5, 2024	EX-3.10	Bylaws of Data Niche Associates, Inc. EX-3.10 Exhibit 3.10 BYLAWS OF DATA NICHE ASSOCIATES, INC. ARTICLE I PURPOSE, ADOPTION, AMENDMENT, AND CONSTRUCTION OF BYLAWS PURPOSE AND CONTENTS Section 1.01. The purpose of these Bylaws is to set forth certain provisions for the regulation of the affairs of the corporation. The Bylaws may contain any provisions for the regulation and management of the affairs of the corporation not inconsistent
January 5, 2024	EX-3.34	By-laws of IQVIA Medical Education Inc. EX-3.34 Exhibit 3.34 BY-LAWS OF Q.E.D. INTERNATIONAL INC. ARTICLE I - OFFICES The office of the Corporation shall be located in the City, County and State designated in the Certificate of Incorporation. The Corporation may also maintain offices at such other places within or without the United States as the Board of Directors may, from time to time, determine. ARTICLE II - MEETING OF SHAREHOLDERS
January 5, 2024	EX-FILING FEES	Filing Fee Table. EX-FILING FEES Exhibit 107 Calculation of Filing Fee Tables Form S-4 (Form Type) IQVIA Holdings Inc.
January 5, 2024	EX-3.24	By-laws of IQVIA Commercial Finance Inc. EX-3.24 Exhibit 3.24 Now known as IQVIA Commercial Finance Inc. BY-LAWS OF IMS HEALTH INVESTING I, INC. ARTICLE I SHAREOWNERS Section 1. The annual meeting of the shareowners of the corporation for the purpose of electing directors and for the transaction of such other business as may properly be brought before the meeting shall be held on the third Wednesday in April of each year, if not a legal
January 5, 2024	EX-3.51	Amended and Restated Certificate of Incorporation of Med-Vantage, Inc., as amended EX-3.51 Exhibit 3.51 CERTIFICATE OF MERGER of IMS REDWOOD ACQUISITION CORPORATION, a Delaware Corporation with and into MED-VANTAGE, INC., a Delaware Corporation Pursuant to Title 8, Section 251 of the Delaware General Corporation Law, the undersigned corporation does hereby certify: FIRST: The name and state of incorporation of each of the constituent corporations of the merger is as follows: Nam
January 5, 2024	EX-3.12	Amended and Restated By-laws of IMS Software Services Ltd. EX-3.12 Exhibit 3.12 AMENDED AND RESTATED BY-LAWS OF IMS SOFTWARE SERVICES, LTD. ARTICLE I SHAREOWNERS Section 1. The annual meeting of the shareowners of the corporation for the purpose of electing directors and for the transaction of such other business as may properly be brought before the meeting shall be held on the third Wednesday in April of each year, if not a legal holiday, and if a legal
January 5, 2024	EX-3.35	Articles of Incorporation of IQVIA Pharma Inc., as amended EX-3.35 Exhibit 3.35 QUINTILES PHARMA, INC. ARTICLES OF INCORPORATION The undersigned, hereby submits these Articles of Incorporation for the purpose of forming a business corporation under and by virtue of the laws of the State of North Carolina: 1. The name of the corporation is Quintiles Pharma, Inc. 2. The corporation shall have authority to issue one thousand (1,000) shares, all of one class,
January 5, 2024	EX-3.16	By-laws of Intercontinental Medical Statistics International, Ltd. EX-3.16 Exhibit 3.16 BY-LAWS of INTERCONTINENTAL MEDICAL STATISTICS INTERNATIONAL, LTD. ARTICLE I SHAREOWNERS Section 1. The annual meeting of the shareowners of the corporation for the purpose of electing directors and for the transaction of such other business as may properly be brought before the meeting shall be held on the third Wednesday in April of each year, if not a legal holiday, and if
January 5, 2024	EX-3.25	Certificate of Incorporation of IQVIA Commercial India Holdings Corp., as amended EX-3.25 Exhibit 3.25 CERTIFICATE OF INCORPORATION OF COGNIZANT INDIA HOLDING CORPORATION * * * * * * * * * * * * * First: The name of the corporation is: Cognizant India Holding Corporation Second: The address of its registered office in the State of Delaware is Corporation Trust Center, 1 209 Orange Street, in the City of Wilmington, County of New Castle. The name of its registered agent at such
January 5, 2024	EX-3.7	Certificate of Formation of BuzzeoPDMA LLC EX-3.7 Exhibit 3.7 CERTIFICATE OF FORMATION OF BUZZEOPDMA LLC 1. The name of the limited liability company is BuzzeoPDMA LLC. 2. The address of its registered office in the State of Delaware is: Corporation Trust Center, 1209 Orange Street, in the City of Wilmington, Delaware 19801. The name of its registered agent at such address is The Corporation Trust Company. 3. The limited liability company
January 5, 2024	EX-3.20	Limited Liability Company Agreement of IQVIA Biotech LLC (f/k/a Novella Clinical LLC), as amended EX-3.20 Exhibit 3.20 Now known as IQVIA Biotech LLC NOVELLA CLINICAL LLC Limited Liability Company Agreement THIS LIMITED LIABILITY COMPANY AGREEMENT of NOVELLA CLINICAL LLC, a limited liability company organized pursuant to the Delaware Limited Liability Company Act (the “Company”), is executed effective as of January 1, 2015, by its sole member, Quintiles, Inc., a North Carolina corporation. ART
January 5, 2024	EX-3.57	Certificate of Formation of RX India, LLC EX-3.57 Exhibit 3.57 STATE OF DELAWARE CERTIFICATE OF CONVERSION FROM A CORPORATION TO A LIMITED LIABILITY COMPANY PURSUANT TO SECTION 18-214 OF THE LIMITED LIABILITY ACT 1.) The jurisdiction where the Corporation first formed is Delaware. 2.) The jurisdiction immediately prior to filing this Certificate is Delaware. 3.) The date the corporation first formed is September 12, 1996. 4.) The name of
January 5, 2024	EX-3.18	Limited Liability Company Agreement of IQVIA BioSciences Holdings, LLC EX-3.18 Exhibit 3.18 Now known as IQVIA BioSciences Holdings, LLC QUINTILES BIOSCIENCES HOLDINGS, LLC Limited Liability Company Agreement THIS LIMITED LIABILITY COMPANY AGREEMENT of QUINTILES BIOSCIENCES HOLDINGS, LLC, a limited liability company organized pursuant to the Delaware Limited Liability Company Act (the “Company”), is executed effective as of 12:00 p.m. U.S. Eastern Time on June 26, 20
January 5, 2024	EX-3.62	Amended and Restated Limited Liability Company Agreement of ValueMedics Research, LLC EX-3.62 Exhibit 3.62 AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT OF VALUEMEDICS RESEARCH, LLC This Amended and Restated Limited Liability Company Agreement (this “Agreement”) is entered into as of the 23rd day of February, 2010, by IMS Health Incorporated (such person and any other person admitted as a member of the Company pursuant to Section 15 hereof individually referred to herein
January 5, 2024	EX-3.32	By-laws of IQVIA Medical Communications & Consulting, Inc. EX-3.32 Exhibit 3.32 Now known as IQVIA Medical Communications & Consulting Inc. BY-LAWS OF MedCom, Inc. ARTICLE I OFFICES Section 1. Principal Office. The principal office of the corporation shall be at 27 Lowell Drive, Wayne, New Jersey 07470, and the name of the registered agent in charge thereof and upon whom process against the corporation can be served is Henry M. Matri, Esq., Cole, Schotz,
January 5, 2024	EX-3.36	Bylaws of IQVIA Pharma Inc. EX-3.36 Exhibit 3.36 Now known as IQVIA Pharma Inc. QUINTILES PHARMA, INC. BYLAWS ARTICLE I DEFINITIONS In these bylaws, unless otherwise provided, the following terms shall have the following meanings: (1) “Act” shall mean the North Carolina Business Corporation Act as codified in Chapter 55 of the General Statutes of North Carolina, as amended from time to time; (2) “Articles of incorporation” s
January 5, 2024	EX-3.23	Certificate of Incorporation of IQVIA Commercial Finance Inc., as amended EX-3.23 Exhibit 3.23 CERTIFICATE OF INCORPORATION of IMS HEALTH INVESTING I, INC. * * * * * * * * * First; The name of the corporation is: IMS Health Investing I, Inc. Second: The address of its registered office in the State of Delaware is Corporation Trust Center. 1209 Orange Street, in the City of Wilmington, County of New Castle. The name of its registered agent at such address is The Corporat
January 5, 2024	EX-3.39	Articles of Organization of IQVIA Phase One Services LLC, as amended EX-3.39 Exhibit 3.39 ARTICLES OF INCORPORATION OF QUINTILES PHASE ONE SERVICES, INC. The undersigned, a natural person, for the purpose of incorporating or organizing a corporation for conducting the business and promoting the purposes hereinafter stated, under the provisions and subject to the requirements of the Kansas General Corporation Code, as amended and supplemented, does hereby adopt the
January 5, 2024	EX-3.61	Certificate of Formation of ValueMedics Research, LLC, as amended EX-3.61 Exhibit 3.61 CERTIFICATE OF FORMATION OF ValueMedics, LLC (Pursuant to the Limited Liability Company Act of the State of Delaware, Title 6) The undersigned, as an authorized person, in order to form a limited liability company pursuant to the Limited Liability Company Act of the State of Delaware, does hereby certify as follows: 1. The name of the company is ValueMedics, LLC (the “Company”
January 5, 2024	EX-3.68	Limited Liability Company Agreement of Q Squared Solutions LLC EX-3.68 Exhibit 3.68 Quintiles Laboratories, LLC Limited Liability Company Agreement THIS LIMITED LIABILITY COMPANY AGREEMENT of Quintiles Laboratories, LLC (the “Company”), a limited liability company organized pursuant to the North Carolina Limited Liability Company Act, is executed effective as of December 31, 2011, by and between the Company and its sole Member, Quintiles, Inc., a North Caroli
January 5, 2024	EX-3.70	Second Amended Limited Liability Company Agreement of Q Squared Solutions Holdings LLC EX-3.70 Exhibit 3.70 SECOND AMENDED LIMITED LIABILITY COMPANY AGREEMENT OF Q SQUARED SOLUTIONS HOLDINGS LLC This Second Amended and Restated Operating Agreement (the “Agreement”) of Q Squared Solutions Holdings LLC, a limited liability company organized under the Laws of the State of Delaware (the “Company”), effective as of April 1, 2021 (the “Effective Date”), is entered into by and between (i)
January 5, 2024	EX-25.1	Form T-1 Statement of Eligibility under the Trust Indenture Act of 1939. EX-25.1 Exhibit 25.1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ☐ Check if an Application to Determine Eligibility of a Trustee Pursuant to Section 305(b)(2) U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION (Exact name of Trustee as specified in its charter) 91-1821036
January 5, 2024	EX-3.14	Bylaws of Innovex Merger Corp. EX-3.14 Exhibit 3.14 Bylaws of Innovex Merger Corp. ARTICLE I DEFINITIONS In these bylaws, unless otherwise provided, the following terms shall have the following meanings: (1) “Act” shall mean the North Carolina Business Corporation Act as codified in Chapter 55 of the North Carolina General Statutes effective July 1, 1990, and as amended from time to time; (2) “Articles of incorporation” shall m
January 5, 2024	EX-3.29	Certificate of Incorporation of IQVIA Government Solutions Inc., as amended EX-3.29 Exhibit 3.29 CERTIFICATE OF INCORPORATION of IMS GOVERNMENT SOLUTIONS, INC. * * * * * * * * * First: The name of the corporation is: IMS GOVERNMENT SOLUTIONS, INC. Second: The address of its registered office in the State of Delaware is Corporation Trust Center, 1209 Orange Street, in the City of Wilmington, County of New Castle. The name of its registered agent at such address is The Corp
January 5, 2024	EX-3.58	Limited Liability Company Agreement of RX India, LLC EX-3.58 Exhibit 3.58 LIMITED LIABILITY COMPANY AGREEMENT OF RX INDIA, LLC This Limited Liability Company Agreement (this “Agreement”) of RX India, LLC, a Delaware limited liability company, is entered into as of this 10th day of July, 2015, by IMS Health India Holding Corporation, as the sole member (the “Member”). A Certificate of Conversion was executed, delivered, filed and effective as of 11:5
January 5, 2024	EX-3.66	By-laws of VCG-BIO, INC. EX-3.66 Exhibit 3.66 BY-LAWS OF VCG-BIO, INC. TABLE OF CONTENTS ARTICLE I STOCKHOLDERS 1 1.1. Place of Meetings 1 1.2. Annual Meeting 1 1.3. Special Meetings 1 1.4. Notice of Meetings 1 1.5. Voting List 1 1.6. Quorum 2 1.7. Adjournments 2 1.8. Voting and Proxies 2 1.9. Action at Meeting 2 1.10. Conduct of Meetings 3 1.11. Action without Meeting 3 ARTICLE II DIRECTORS 4 2.1. General Powers 4 2.2. N
January 5, 2024	EX-99.2	Form of Letter to Holders. EX-99.2 Exhibit 99.2 IQVIA INC. OFFER TO EXCHANGE $750,000,000 AGGREGATE PRINCIPAL AMOUNT OF ITS 5.700% SENIOR SECURED NOTES DUE 2028 AND $1,250,000,000 AGGREGATE PRINCIPAL AMOUNT OF ITS 6.250% SENIOR SECURED NOTES DUE 2029, THE ISSUANCE OF WHICH HAS BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, FOR ANY AND ALL OF ITS OUTSTANDING 5.700% SENIOR SECURED NOTES DUE 2028 AND ANY AND ALL
January 5, 2024	EX-3.33	Certificate of Incorporation of IQVIA Medical Education Inc., as amended EX-3.33 Exhibit 3.33 CERTIFICATE OF INCORPORATION OF Q.E.D. INTERNATIONAL, INC. Under Section 402 of the Business Corporation Law The undersigned, being a natural person of at least 18 years of age and acting as the incorporator of the corporation hereby being formed under the Business Corporation Law, certifies that: FIRST: The name of the corporation is Q.E.D. INTERNATIONAL, INC. SECOND: The cor
January 5, 2024	EX-3.48	By-laws of IQVIA Trading Management Inc. EX-3.48 Exhibit 3.48 Now known as IQVIA Trading Management Inc. BY-LAWS of IMS TRADING MANAGEMENT, INC. ARTICLE I STOCKHOLDERS Section 1. Annual Meetings. An annual meeting of stockholders shall be held for the election of directors at such date, time and place either within or without the State of Delaware as may be designated by the Board of Directors from time to time. Any other proper business
January 5, 2024	EX-5.3	Opinion of Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan, LLP North Carolina counsel to the Company. EX-5.3 Exhibit 5.3 SMITH, ANDERSON, BLOUNT, DORSETT, MITCHELL & JERNIGAN, L.L.P. LAWYERS OFFICES Wells Fargo Capitol Center 150 Fayetteville Street, Suite 2300 Raleigh, North Carolina 27601 - January 5, 2024 MAILING ADDRESS P.O. Box 2611 Raleigh, North Carolina 27602-2611 - TELEPHONE: (919) 821-1220 FACSIMILE: (919) 821-6800 IQVIA Inc. 2400 Ellis Road Durham, North Carolina 27703 Re: IQVIA Inc. 5.
January 5, 2024	EX-3.28	By-laws of IQVIA Commercial Trading Corp. EX-3.28 Exhibit 3.28 Now known as IQVIA Commercial Trading Corp. COGNIZANT TRADING CORPORATION BY-LAWS AS OF APRIL 30, 1997 ARTICLE I OFFICES Section 1. The principal office of Cognizant Trading Corporation. (hereinafter the “Corporation”) in the State of Delaware shall be located at Pennsylvania Railroad Building, 110 So. French Street, Suite 402, Wilmington, Delaware 19801. Section 2. The Corpor
January 5, 2024	EX-3.21	Certificate of Incorporation of IQVIA Chinametrik Inc., as amended EX-3.21 Exhibit 3.21 CERTIFICATE OF INCORPORATION of IMS CHINAMETRIK INCORPORATED * * * * * * * * * First: The name of the corporation is: IMS ChinaMetrik Incorporated Second: The address of its registered office in the State of Delaware is Corporation Trust Center, 1209 Orange Street, in the City of Wilmington, County of New Castle. The name of its registered agent at such address is The Corporat
January 5, 2024	EX-3.5	Articles of Incorporation of Benefit Holding, Inc. EX-3.5 Exhibit 3.5 ARTICLES OF INCORPORATION OF BENEFIT HOLDING, INC. The undersigned does hereby submit these Articles of Incorporation for the purpose of forming a business corporation under and by virtue of the laws of the State of North Carolina: 1. The name of the corporation is Benefit Holding, Inc. 2. The corporation shall have authority to issue One Hundred Thousand (100,000) shares of com
January 5, 2024	EX-3.55	Certificate of Incorporation of IQVIA CSMS US Inc., as amended EX-3.55 Exhibit 3.55 State of North Carolina Department of the Secretary of State ARTICLES OF INCORPORATION Pursuant to §55-2-02 of the General Statutes of North Carolina, the undersigned does hereby submit these Articles of Incorporation for the purpose of forming a business corporation. 1. The name of the corporation is: Innovex, Inc. 2. The number of shares the corporation is authorized to issu
January 5, 2024	EX-3.54	Limited Liability Company Agreement of Outcome Sciences, LLC EX-3.54 Exhibit 3.54 OUTCOME SCIENCES, LLC Limited Liability Company Agreement THIS LIMITED LIABILITY COMPANY AGREEMENT of OUTCOME SCIENCES, LLC, a limited liability company organized pursuant to the Delaware Limited Liability Company Act (the “Company”), is executed effective as of January 1, 2015, by its sole member, Quintiles, Inc., a North Carolina corporation. ARTICLE I FORMATION OF THE COMPA
January 5, 2024	EX-3.50	By-laws of IQVIA Transportation Services Corp. EX-3.50 Exhibit 3.50 Now known as IQVIA Transportation Services Corp. BY-LAWS of D & B TRANSPORTATION SERVICES COMPANY, INC. ARTICLE I STOCKHOLDERS SECTION 1. The annual meeting of the stockholders of the corporation for the purpose of electing directors and for the transaction of such other business as may properly be brought before the meeting shall be held on the third Wednesday in April of eac
January 5, 2024	EX-3.44	Bylaws of IQVIA RDS Inc. EX-3.44 Exhibit 3.44 Now known as IQVIA RDS Inc. Amended and Restated Bylaws of Quintiles, Inc. ARTICLE I DEFINITIONS In these bylaws, unless otherwise provided, the following terms shall have the following meanings: (1) “Act” shall mean the North Carolina Business Corporation Act as codified in Chapter 55 of the North Carolina General Statutes effective July 1, 1990, and as amended from time to t
January 5, 2024	EX-99.1	Letter of Transmittal. EX-99.1 Exhibit 99.1 IQVIA INC. LETTER OF TRANSMITTAL OFFER TO EXCHANGE $750,000,000 AGGREGATE PRINCIPAL AMOUNT OF ITS 5.700% SENIOR SECURED NOTES DUE 2028 AND $1,250,000,000 AGGREGATE PRINCIPAL AMOUNT OF ITS 6.250% SENIOR SECURED NOTES DUE 2029, THE ISSUANCE OF WHICH HAS BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, FOR ALL OF ITS OUTSTANDING 5.700% SENIOR SECURED NOTES DUE 2028 A
January 5, 2024	EX-3.72	Bylaws of QCare Site Services, Inc EX-3.72 Exhibit 3.72 Now known as QCare Site Services, Inc. QUINTILES FEDERATED SERVICES, INC. BYLAWS ARTICLE I DEFINITIONS In these bylaws, unless otherwise provided, the following terms shall have the following meanings: (1) “Act” shall mean the North Carolina Business Corporation Act as codified in Chapter 55 of the North Carolina General Statutes effective July 1, 1990, and as amended from tim
January 5, 2024	EX-3.52	By-laws of Med-Vantage, Inc. EX-3.52 Exhibit 3.52 Now known as Med-Vantage, Inc. BY-LAWS OF IMS REDWOOD ACQUISITION CORPORATION Section 1. LAW, CERTIFICATE OF INCORPORATION AND BY-LAWS 1.1. These by-laws are subject to the certificate of formation of the corporation. In these by-laws, references to law, the certificate of incorporation and by-laws mean the law, the provisions of the certificate of incorporation and the by-law
January 5, 2024	EX-3.37	Articles of Incorporation of IQVIA Pharma Services Corp., as amended EX-3.37 Exhibit 3.37 QUINTILES PHARMA SERVICES CORP. ARTICLES OF INCORPORATION The undersigned, hereby submits these Articles of Incorporation for the purpose of forming a business corporation under and by virtue of the laws of the State of North Carolina: 1. The name of the corporation is Quintiles Pharma Services Corp. 2. The corporation shall have authority to issue one thousand (1,000) shares,
January 5, 2024	EX-3.31	Certificate of Incorporation of IQVIA Medical Communications & Consulting, Inc., as amended Exhibit 3.31 CERTIFICATE OF INCORPORATION OF MedCom Inc. To: The Secretary of State State of New Jersey The undersigned, of the age of eighteen years or over, for the purpose of forming a corporation pursuant to the provisions of Title 14A, Corporations, General, of the New Jersey Statutes, does hereby execute the following Certificate of Incorporation. (1) The name of the corporation is MedCom In
January 5, 2024	EX-3.40	Limited Liability Company Agreement of IQVIA Phase One Services LLC EX-3.40 Exhibit 3.40 Now known as IQVIA Phase One Services LLC Quintiles Phase One Services, LLC Limited Liability Company Agreement THIS LIMITED LIABILITY COMPANY AGREEMENT of Quintiles Phase One Services, LLC (the “Company”), a limited liability company organized pursuant to the Kansas Limited Liability Company Act, is executed effective as of December 31, 2011 by and between the Company and its
January 5, 2024	EX-10.1	Registration Rights Agreement, dated May 23, 2023, among IQVIA Inc., IQVIA Holdings Inc., certain subsidiaries of the Issuer as guarantors, and Goldman Sachs & Co. LLC as representative of the several initial purchasers. EX-10.1 Exhibit 10.1 REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT dated May 23, 2023 (this “Agreement”) is entered into by and among IQVIA Inc., a Delaware corporation (the “Issuer”), IQVIA Holdings Inc., a Delaware corporation (the “Parent”), the subsidiaries of the Issuer party hereto (the “Subsidiary Guarantors” and, together with the Parent, the “Initial Guarantors”) and Go
January 5, 2024	EX-3.38	Bylaws of IQVIA Pharma Services Corp. EX-3.38 Exhibit 3.38 Now known as IQVIA Pharma Services Corp. QUINTILES PHARMA SERVICES CORP. BYLAWS ARTICLE I DEFINITIONS In these bylaws, unless otherwise provided, the following terms shall have the following meanings: (1) “Act” shall mean the North Carolina Business Corporation Act as codified in Chapter 55 of the General Statutes of North Carolina, as amended from time to time; (2) “Articles
January 5, 2024	EX-3.53	Certificate of Formation of Outcome Sciences, LLC EX-3.53 Exhibit 3.53 STATE OF DELAWARE LIMITED LIABILITY COMPANY CERTIFICATE OF FORMATION First: The name of the limited liability company is Outcome Sciences, LLC. Second: The address of its registered office in the State of Delaware is 1209 Orange Street in the City of Wilmington, Zip Code 19801. The name of its Registered Agent at such address is The Corporation Trust Company. Third: This Certi
January 5, 2024	EX-3.17	Certificate of Formation of IQVIA BioSciences Holdings, LLC, as amended EX-3.17 Exhibit 3.17 STATE OF DELAWARE LIMITED LIABILITY COMPANY CERTIFICATE OF FORMATION First: The name of the limited liability company is Quintiles BioSciences Holdings, LLC. Second: The address of its registered office in the State of Delaware is 1209 Orange Street in the City of Wilmington, Zip Code 19801. The name of its Registered Agent at such address is The Corporation Trust Company. Thi
January 5, 2024	EX-3.41	Articles of Incorporation of IQVIA RDS Asia Inc., as amended EX-3.41 Exhibit 3.41 ARTICLES OF INCORPORATION OF Quintiles Asia, Inc. Pursuant to Section 55-2-02 of the General Statutes of North Carolina, the undersigned does hereby submit these Articles of Incorporation for the purpose of forming a business corporation. 1. The name of the corporation is Quintiles Asia, Inc. 2. The number of shares the corporation is authorized to issue is 25,000. These share
January 5, 2024	EX-3.56	By-laws of IQVIA CSMS US Inc. EX-3.56 Exhibit 3.56 Now known as Quintiles Commercial US, Inc. BY-LAWS OF THE MSM GROUP, INC. (a Delaware corporation) ARTICLE I OFFICES Section 1. Registered Office. The registered office of the corporation shall be located in the City of Wilmington, County of New Castle, State of Delaware. Section 2. Other Offices. The corporation may have offices at such other places both within and without th
January 5, 2024	EX-3.27	Certificate of Incorporation of IQVIA Commercial Trading Corp., as amended EX-3.27 Exhibit 3.27 CERTIFICATE OF INCORPORATION -OF- PJH TECHNOLOGY SOLUTIONS, LTD. FIRST: The name of the Corporation is PJH Technology Solutions, Ltd. (hereinafter the “Corporation”). SECOND: The address of the registered office of the Corporation in the State of Delaware is Corporation Trust Center, 1209 Orange Street in the City of Wilmington, County of New Castle. The name of its registered
January 5, 2024	EX-4.8	Amended and Restated Indenture, dated December 19, 2023, among IQVIA Inc., as Issuer, U.S. Bank Trust Company, National Association, as trustee of the 5.700% Senior Secured Notes due 2028 and the Company and certain subsidiaries of the Issuer as guarantors. EX-4.8 Exhibit 4.8 AMENDED AND RESTATED INDENTURE Dated as of December 19, 2023 among IQVIA Inc., as Issuer, the Guarantors party hereto and U.S. Bank Trust Company, National Association, as Trustee and as Collateral Agent 5.700% SENIOR SECURED NOTES DUE 2028 CROSS-REFERENCE TABLE Trust Indenture Act Section Indenture Section 310 (a)(1) 7.10 (a)(2) 7.10 (a)(3) N.A. (a)(4) N.A. (a)(5) 7.10 (b) 7.03
January 5, 2024	EX-3.45	Articles of Organization of IQVIA RDS Latin America LLC, as amended EX-3.45 Exhibit 3.45 State of North Carolina Department of the Secretary of State ARTICLES OF ORGANIZATION INCLUDING ARTICLES OF CONVERSION Pursuant to §§ 57C-2-21, 57C-9A-01 and 57C-9A-03 of the General Statutes of North Carolina, the undersigned converting business entity does hereby submit these Articles of Organization Including Articles of Conversion for the purpose of forming a limited liabi
January 5, 2024	EX-3.19	Certificate of Formation of IQVIA Biotech LLC (f/k/a Novella Clinical LLC), as amended EX-3.19 Exhibit 3.19 STATE OF DELAWARE LIMITED LIABILITY COMPANY CERTIFICATE OF FORMATION First: The name of the limited liability company is Novella Clinical LLC. Second: The address of its registered office in the State of Delaware is 1209 Orange Street in the City of Wilmington , Zip Code 19801 . The name of its Registered Agent at such address is The Corporation Trust Company . Third: Th
January 5, 2024	EX-3.60	Amended and Restated Operating Agreement of Targeted Molecular Diagnostics, LLC, as amended EX-3.60 Exhibit 3.60 AMENDED AND RESTATED OPERATING AGREEMENT OF TARGETED MOLECULAR DIAGNOSTICS, LLC THIS AMENDED AND RESTATED OPERATING AGREEMENT (the “Agreement”) of Targeted Molecular Diagnostics, LLC (the “Company”), a limited liability company organized pursuant to the Illinois Limited Liability Company Act (the “Act”), is executed effective as of November 25, 2008 by and between the Company
January 5, 2024	EX-22.1	List of Subsidiary Guarantors and Affiliates who Collateralize the Company’s Securities EX-22.1 Exhibit 22.1 IQVIA Inc. Subsidiary Guarantors and Issuers of Guaranteed Securities and Affiliates Whose Securities Collateralize a Registrant’s Securities The following entities are, as of the date of the filing of the registration statement of which this exhibit is a part, guarantors of IQVIA Inc.’s (the “Issuer”) 5.700% Senior Secured Notes due 2028 and 6.250% Senior Secured Notes due 20
January 5, 2024	EX-3.6	Bylaws of Benefit Holding, Inc. EX-3.6 Exhibit 3.6 BYLAWS OF BENEFIT HOLDING, INC. ARTICLE I DEFINITIONS In these bylaws, unless otherwise provided, the following terms shall have the following meanings: (1) “Act” shall mean the North Carolina Business Corporation Act as codified in Chapter 55 of the North Carolina General Statutes effective July 1, 1990, and as amended from time to time; (2) “Articles of incorporation” shall me
January 5, 2024	EX-3.15	Certificate of Incorporation of Intercontinental Medical Statistics International, Ltd., as amended EX-3.15 Exhibit 3.15 CERTIFICATE OF INCORPORATION OF INTERCONTINENTAL MEDICAL STATISTICS INTERNATIONAL, LTD. FIRST: The name of the Corporation is Intercontinental Medical Statistics International, Ltd. (hereinafter the “Corporation”). SECOND: The address of the registered office of the Corporation in the State of Delaware is Corporation Trust Center, 1209 Orange Street in the City of Wilmington,
January 5, 2024	EX-3.11	Amended and Restated Certificate of Incorporation of IMS Software Services Ltd. EX-3.11 Exhibit 3.11 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF IMS SOFTWARE SERVICES LTD. Pursuant to Sections 242 and 245 of The General Corporation Law of the State of Delaware IMS Software Services Ltd. (the “Corporation”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “GCL”), in order to amend and restate its Ce
January 5, 2024	EX-3.42	Amended and Restated Bylaws of IQVIA RDS Asia Inc. EX-3.42 Exhibit 3.42 Now known as IQVIA RDS Asia Inc. AMENDED AND RESTATED BYLAWS OF QUINTILES ASIA, INC. ARTICLE I DEFINITIONS In these bylaws, unless otherwise provided, the following terms shall have the following meanings: 1. “Act” shall mean the North Carolina Business Corporation Act as codified in Chapter 55 of the North Carolina General Statutes effective July 1, 1990, and as amended from
January 5, 2024	EX-10.2	Registration Rights Agreement, dated November 28, 2023, among IQVIA Inc., IQVIA Holdings Inc., certain subsidiaries of the Issuer as guarantors, and J.P. Morgan Securities LLC as representative of the several initial purchasers. EX-10.2 Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT dated November 28, 2023 (this “Agreement”) is entered into by and among IQVIA Inc., a Delaware corporation (the “Issuer”), IQVIA Holdings Inc., a Delaware corporation (the “Parent”), the subsidiaries of the Issuer party hereto (the “Subsidiary Guarantors” and, together with the Parent, the “Initial Guarantors”) a
January 5, 2024	EX-3.47	Certificate of Incorporation of IQVIA Trading Management Inc., as amended Exhibit 3.47 CERTIFICATE OF INCORPORATION of IMS TRADING MANAGEMENT, INC. First. The name of the corporation is IMS Trading Management, Inc. Second. The address of the corporation’s registered office in the State of Delaware is Corporation Trust Center, 1209 Orange Street, in the City of Wilmington, County of New Castle. The name of its registered agent at such address is The Corporation Trust Com
January 5, 2024	EX-3.3	Amended and Restated Certificate of Incorporation of IQVIA Inc., as amended EX-3.3 Exhibit 3.3 QUINTILES IMS INCORPORATED CERTIFICATE OF AMENDMENT TO CERTIFICATE OF INCORPORATION Quintiles IMS Incorporated (the “Corporation”), a corporation organized and existing under the laws of the State of Delaware, hereby certifies as follows: 1. That the Board of Directors of the Corporation, by the written consent of its members, adopted resolutions proposing and declaring advisabl
January 5, 2024	EX-4.9	Amended and Restated Indenture, dated December 19, 2023, among IQVIA Inc., as Issuer, U.S. Bank Trust Company, National Association, as trustee of the 6.250% Senior Secured Notes due 2029 and the Company and certain subsidiaries of the Issuer as guarantors. EX-4.9 Exhibit 4.9 AMENDED AND RESTATED INDENTURE Dated as of December 19, 2023 among IQVIA Inc., as Issuer, the Guarantors party hereto and U.S. Bank Trust Company, National Association, as Trustee and as Collateral Agent 6.250% SENIOR SECURED NOTES DUE 2029 CROSS-REFERENCE TABLE* Trust Indenture Act Section Indenture Section 310 (a)(1) 7.10 (a)(2) 7.10 (a)(3) N.A. (a)(4) N.A. (a)(5) 7.10 (b) 7.0
January 5, 2024	S-4	As filed with the Securities and Exchange Commission on January 5, 2024 Table of Contents As filed with the Securities and Exchange Commission on January 5, 2024 Registration No.
January 5, 2024	EX-3.49	Certificate of Incorporation of IQVIA Transportation Services Corp., as amended EX-3.49 Exhibit 3.49 CERTIFICATE OF INCORPORATION OF D & B TRANSPORTATION SERVICES COMPANY, INC. * * * * * 1. The name of the corporation is D & B Transportation Services Company, Inc. 2. The address of its registered office in the State of Delaware is Corporation Trust Center, 1209 Orange Street, City of Wilmington, County of New Castle. The name of its registered agent at such address is The Cor
November 28, 2023	EX-10.1	Amendment No. 3 to Fifth Amended and Restated Credit Agreement, dated November 28, 2023, among IQVIA Inc., IQVIA Holdings Inc., IQVIA RDS Inc., IQVIA AG, IQVIA Solutions Japan LLC, the other guarantors party thereto, Bank of America, N.A. as administrative agent and as collateral agent, and the Lenders party thereto. Exhibit 10.1 AMENDMENT NO. 3 TO FIFTH AMENDED AND RESTATED CREDIT AGREEMENT AMENDMENT NO. 3, dated as of November 28, 2023 (this “Amendment”), among IQVIA Inc., a Delaware corporation (the “Parent Borrower”), IQVIA RDS Inc., a North Carolina corporation and a subsidiary of the Parent Borrower (the “U.S. Borrower”), IQVIA Holdings Inc., a Delaware corporation (“Holdings”), the other guarantors part
November 28, 2023	EX-4.1	Form of 6.250% Senior Secured Notes due 2029 Exhibit 4.1 INDENTURE Dated as of November 28, 2023 among IQVIA Inc., as Issuer, the Guarantors party hereto and U.S. Bank Trust Company, National Association, as Trustee and as Collateral Agent 6.250% SENIOR SECURED NOTES DUE 2029 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS AND INCORPORATION BY REFERENCE SECTION 1.01. Definitions 1 SECTION 1.02. Other Definitions 39 SECTION 1.03. Incorporation b
November 28, 2023	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 28, 2023 IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation) (Commission F
November 15, 2023	EX-99.2	IQVIA Announces Pricing of Upsized Offering of Senior Secured Notes Exhibit 99.2 IQVIA Announces Pricing of Upsized Offering of Senior Secured Notes INNOVATION PARK, N.C.— November 15, 2023—(BUSINESS WIRE)— IQVIA Holdings Inc. (NYSE:IQV) (the “Company”) today announced that its wholly-owned subsidiary, IQVIA Inc. (the “Issuer” or “Borrower”), priced an offering of $1,250 million in aggregate principal amount of senior secured notes due 2029 (the “Notes”), which wa
November 15, 2023	EX-99.1	IQVIA Announces Offering of Senior Secured Notes Exhibit 99.1 IQVIA Announces Offering of Senior Secured Notes INNOVATION PARK, N.C.—November 14, 2023—(BUSINESS WIRE)—IQVIA Holdings Inc. (NYSE:IQV) (the “Company”) today announced that its wholly-owned subsidiary, IQVIA Inc. (the “Issuer” or “Borrower”), intends to raise $500,000,000 through an offering of senior secured notes due 2029 (the “Notes”). Substantially concurrently with the closing of
November 15, 2023	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 14, 2023 IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation) (Commission F
November 1, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-35907 IQV
November 1, 2023	EX-99.1	IQVIA Reports Third-Quarter 2023 Results Exhibit 99.1 IQVIA Reports Third-Quarter 2023 Results Revenue of $3,736 million grew 4.9 percent year-over-year GAAP Net Income of $303 million grew 7.1 percent year-over-year Adjusted EBITDA of $888 million grew 9.1 percent year-over-year GAAP Diluted Earnings per Share of $1.63 grew 9.4 percent year-over-year Adjusted Diluted Earnings per Share of $2.49 grew 0.4 percent year-over-year R&D Soluti
November 1, 2023	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2023 IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation) (Commission Fi
September 26, 2023	8-K	Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 26, 2023 (September 24, 2023) IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorp
September 26, 2023	EX-99.1	IQVIA Appoints Richard Staub III President of Research & Development Solutions Exhibit 99.1 NEWS Contact: Nick Childs, IQVIA Investor Relations ([email protected]) +1.973.316.3828 Trent Brown, IQVIA Media Relations ([email protected]) +1.919.780.3221 IQVIA Appoints Richard Staub III President of Research & Development Solutions RESEARCH TRIANGLE PARK, N.C. – September 25, 2023 – IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions
August 1, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-35907 IQVIA HO
August 1, 2023	EX-99.1	IQVIA Reports Second-Quarter 2023 Results Exhibit 99.1 IQVIA Reports Second-Quarter 2023 Results Revenue of $3,728 million grew 5.3 percent year-over-year on a reported basis and 5.5 percent at constant currency GAAP Net Income of $297 million grew 16.0 percent year-over-year Adjusted EBITDA of $864 million grew 8.0 percent year-over-year GAAP Diluted Earnings per Share of $1.59 grew 18.7 percent year-over-year Adjusted Diluted Earnings p
August 1, 2023	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 1, 2023 IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation) (Commission File
August 1, 2023	EX-10.1	IQVIA Inc. Employee Protection Plan and Summary Plan Description, as amended and restated effective July 1, 2023. Exhibit 10.1 IQVIA Inc. Employee Protection Plan and Summary Plan Description As Amended and Restated Effective July 1, 2023 Introduction This IQVIA Inc. Employee Protection Plan (“Plan”) provides severance benefits to eligible employees of IQVIA Inc. (“IQVIA”) and its Affiliates (as defined below) in the United States, except for any Affiliate which (1) has been designated by the Benefits Committ
May 23, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 23, 2023 IQVIA HOLDINGS INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 23, 2023 IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation) (Commission File N
May 23, 2023	EX-4.2	Indenture, dated May 23, 2023, among IQVIA Inc., as Issuer, U.S. Bank Trust Company, National Association, as trustee of the Senior Notes and certain subsidiaries of the Issuer as guarantors. EX-4.2 Exhibit 4.2 Execution Version INDENTURE Dated as of May 23, 2023 among IQVIA Inc., as Issuer, the Guarantors party hereto, U.S. Bank Trust Company, National Association, as Trustee 6.500% SENIOR NOTES DUE 2030 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS AND INCORPORATION BY REFERENCE SECTION 1.01. Definitions 1 SECTION 1.02. Other Definitions 32 SECTION 1.03. Rules of Construction 32 SECTI
May 23, 2023	EX-4.1	Form of 5.700% Senior Secured Notes due 2028 EX-4.1 Exhibit 4.1 Execution Version INDENTURE Dated as of May 23, 2023 among IQVIA Inc., as Issuer, the Guarantors party hereto and U.S. Bank Trust Company, National Association, as Trustee and as Collateral Agent 5.700% SENIOR SECURED NOTES DUE 2028 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS AND INCORPORATION BY REFERENCE SECTION 1.01. Definitions 1 SECTION 1.02. Other Definitions 38 SECTION 1
May 19, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 18, 2023 IQVIA HOLDINGS INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 18, 2023 IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation) (Commission File N
May 19, 2023	EX-99.2	IQVIA Announces Pricing of Upsized Offering of Senior Secured Notes and Senior Notes EX-99.2 Exhibit 99.2 IQVIA Announces Pricing of Upsized Offering of Senior Secured Notes and Senior Notes INNOVATION PARK, N.C.—May 18, 2023—(BUSINESS WIRE)— IQVIA Holdings Inc. (NYSE:IQV) today announced that its wholly-owned subsidiary, IQVIA Inc. (the “Issuer”), priced an offering of $1,250,000,000 in aggregate principal amount of senior notes, which was upsized due to strong demand, consisting
May 19, 2023	EX-99.1	IQVIA Announces Offering of Senior Secured Notes and Senior Notes EX-99.1 Exhibit 99.1 IQVIA Announces Offering of Senior Secured Notes and Senior Notes INNOVATION PARK, N.C.—May 18, 2023—(BUSINESS WIRE)—IQVIA Holdings Inc. (NYSE:IQV) today announced that its wholly-owned subsidiary, IQVIA Inc. (the “Issuer”), intends to raise $1,000,000,000 through an offering of senior secured notes due 2028 and senior notes due 2030 (collectively, the “Notes”). The proceeds f
April 28, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-35907 IQVIA H
April 27, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ______________ FORM 8-K ______________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): Apr UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 27, 2023 IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation) (Commission File
April 27, 2023	EX-99.1	IQVIA Reports First-Quarter 2023 Results; Reaffirms Full-Year 2023 Guidance Exhibit 99.1 IQVIA Reports First-Quarter 2023 Results; Reaffirms Full-Year 2023 Guidance Revenue of $3,652 million GAAP Net Income of $289 million, Adjusted EBITDA of $851 million GAAP Diluted Earnings per Share of $1.53, Adjusted Diluted Earnings per Share of $2.45 R&D Solutions quarterly bookings of $2.6 billion, representing book-to-bill ratio of 1.28x R&D Solutions contracted backlog of $27.9
April 18, 2023	EX-3.1	Amended and Restated Certificate of Incorporation of IQVIA Holdings Inc., effective April 18, 2023. Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF IQVIA HOLDINGS INC. (Under Sections 242 and 245 of the Delaware General Corporation Law) IQVIA Holdings Inc., a corporation organized and existing under the laws of the State of Delaware, as amended (the “Corporation”), does hereby certify as follows: FIRST. The Corporation filed its original certificate of incorporation with the Sec
April 18, 2023	EX-10.1	Amendment No. 2 to Fifth Amended and Restated Credit Agreement, dated April 17, 2023, among IQVIA Inc., IQVIA Holdings Inc., IQVIA RDS Inc., IQVIA AG, IQVIA Japan K.K., the other guarantors party thereto, Bank of America, N.A. as administrative agent and as collateral agent, and the Lenders party thereto. EXECUTION VERSION AMENDMENT NO. 2 TO FIFTH AMENDED AND RESTATED CREDIT AGREEMENT AMENDMENT NO. 2, dated as of April 17, 2023 (this “Amendment”), among IQVIA Inc., a Delaware corporation (the “Parent Borrower”), IQVIA RDS Inc. a North Carolina corporation and a subsidiary of the Parent Borrower (the “U.S. Borrower”), IQVIA AG, a Swiss corporation and a subsidiary of the Parent Borrower (the “Swiss
April 18, 2023	EX-3.2	Amended and Restated Bylaws of IQVIA Holdings Inc., effective April 18, 2023. Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF IQVIA HOLDINGS INC. SECTION 1 - STOCKHOLDERS Section 1.1. Annual Meeting. An annual meeting of the stockholders of IQVIA Holdings Inc., a Delaware corporation (the “Corporation”), for the election of directors to succeed those whose terms expire and for the transaction of such other business as may properly come before the meeting shall be held at the pla
April 18, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 17, 2023 IQVIA HOLDINGS INC UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 17, 2023 IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation) (Commission File
April 18, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 18, 2023 IQVIA HOLDINGS INC UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 18, 2023 IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation) (Commission File
February 27, 2023	DEF 14A	NOTICE Message from our Lead Independent Director UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No.
February 27, 2023	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No.
February 17, 2023	PRE 14A	NOTICE Message from our Lead Independent Director UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No.
February 15, 2023	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-35907 IQVIA HOLDIN
February 15, 2023	EX-21.1	IQVIA Holdings Inc. Subsidiary Listing—as of 12/ 31/2022 Exhibit 21.1 IQVIA Holdings Inc. Subsidiary Listing - as of 12/31/2022 Subsidiary Jurisdiction or State of Organization 159 Solutions, LLC California 159 Technology Solutions Private Ltd India AECIO IT Solutions India Private Ltd. India AHM Global Services, LLC New Jersey AIT Bioscience LLC Indiana Albatross Financial Solutions Limited England ALIMED Egeszsegugyi Szolgaltato Kft. Hungary Allcare P
February 15, 2023	EX-10.59	Letter Agreement between the Company and Costa Panagos, effective on April 1, 2022 Exhibit 10.59 March 28, 2022 Dear Costa, In accordance with our discussions regarding the new role you are transitioning to, included is information about that new role for your review, including details about salary and job expectations. Sincerely, /s/ Trudy Stein Trudy Stein Chief Human Resources Officer Name: Constantinos Panagos Start date: April 1, 2022 Position Title / Level: President, Re
February 13, 2023	EX-3.1	Amended and Restated Bylaws of IQVIA Holdings Inc., effective April 18, 2023. AMENDED AND RESTATED BYLAWS OF IQVIA HOLDINGS INC. SECTION 1 - STOCKHOLDERS Section 1.1. Annual Meeting. An annual meeting of the stockholders of IQVIA Holdings Inc., a Delaware corporation (the “Corporation”), for the election of directors to succeed those whose terms expire and for the transaction of such other business as may properly come before the meeting shall be held at the place, if any,
February 13, 2023	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: February 13, 2023 IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identifi
February 10, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ______________ FORM 8-K ______________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): Feb UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 10, 2023 IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation) (Commission F
February 10, 2023	EX-99.1	IQVIA Reports Fourth-Quarter and Full-Year 2022 Results; Issues Full-Year 2023 Guidance Exhibit 99.1 IQVIA Reports Fourth-Quarter and Full-Year 2022 Results; Issues Full-Year 2023 Guidance Revenue of $3,739 million for the fourth quarter, $14,410 million for the full year GAAP Net Income of $227 million for the fourth quarter, $1,091 million for the full year Adjusted EBITDA of $920 million for the fourth quarter, $3,346 million for the full year GAAP Diluted Earnings per Share of $1
February 9, 2023	SC 13G/A	IQV / Iqvia Holdings Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv01186-iqviaholdingsinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 9)* Name of issuer: IQVIA Holdings Inc. Title of Class of Securities: Common Stock CUSIP Number: 46266C105 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designa
October 27, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-35907 IQV
October 26, 2022	EX-99.1	IQVIA Reports Third-Quarter 2022 Results Exhibit 99.1 IQVIA Reports Third-Quarter 2022 Results Revenue of $3,562 million grew 5.0 percent year-over-year on a reported basis and 10.5 percent at constant currency GAAP Net Income of $283 million grew 8.4 percent year-over-year Adjusted EBITDA of $814 million increased 11.8 percent year-over-year GAAP Diluted Earnings per Share of $1.49 grew 11.2 percent year-over-year Adjusted Diluted Earni
October 26, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 26, 2022 IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation) (Commission Fi
October 3, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 3, 2022 (October 2, 2022) IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporatio
September 29, 2022	CORRESP	September 29, 2022 201 Broadway Cambridge, MA 02139 www.iqvia.com September 29, 2022 VIA EDGAR Christopher Dunham Amanda Ravitz United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 RE: IQVIA Holdings Inc. Definitive Proxy Statement on Schedule 14A Filed February 28, 2022 File No. 001-35907 Dear Mr. Dunham and Ms. Ravitz, The purpose of this letter
July 29, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 29, 2022 (July 25, 2022) IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation) (
July 22, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-35907 IQVIA HO
July 21, 2022	EX-99.1	IQVIA Reports Second-Quarter 2022 Results Exhibit 99.1 IQVIA Reports Second-Quarter 2022 Results Revenue of $3,541 million grew 3.0 percent year-over-year on a reported basis and 7.1 percent at constant currency GAAP Net Income of $256 million grew 46.3 percent year-over-year Adjusted EBITDA of $800 million grew 10.8 percent year-over-year GAAP Diluted Earnings per Share of $1.34 grew 48.9 percent year-over-year Adjusted Diluted Earnings
July 21, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 21, 2022 IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation) (Commission File
June 16, 2022	EX-10.1	Amendment No. 1 to Fifth Amended and Restated Credit Agreement, dated June 16, 2022, among IQVIA Inc., IQVIA Holdings Inc., IQVIA RDS Inc. the other guarantors party thereto, Bank of America, N.A. as administrative agent and as collateral agent, and the Lenders party thereto. Exhibit 10.1 Execution Version AMENDMENT NO. 1 TO FIFTH AMENDED AND RESTATED CREDIT AGREEMENT AMENDMENT NO. 1, dated as of June 16, 2022 (this ?Amendment?), among IQVIA Inc., a Delaware corporation (the ?Parent Borrower?), IQVIA RDS Inc. a North Carolina corporation and a subsidiary of the Parent Borrower (the ?U.S. Borrower?), IQVIA Holdings Inc., a Delaware corporation (?Holdings?), the other gu
June 16, 2022	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 16, 2022 IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation) (Commission File
April 28, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-35907 IQVIA H
April 27, 2022	8-K	Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 27, 2022 IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation) (Commission File
April 27, 2022	EX-99.1	IQVIA Reports First-Quarter 2022 Results Exhibit 99.1 IQVIA Reports First-Quarter 2022 Results Revenue of $3,568 million increased 4.7 percent year-over-year on a reported basis and 6.8 percent at constant currency GAAP Net Income of $325 million grew 53.3 percent year-over-year Adjusted EBITDA of $812 million grew 9.1 percent year-over-year GAAP Diluted Earnings per Share of $1.68 grew 54.1 percent year-over-year Adjusted Diluted Earnin
April 14, 2022	EX-3.1	Amended and Restated Certificate of Incorporation of IQVIA Holdings Inc., effective April 1 Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF IQVIA HOLDINGS INC. (Under Sections 242 and 245 of the Delaware General Corporation Law) IQVIA Holdings Inc., a corporation organized and existing under the laws of the State of Delaware, as amended (the ?Corporation?), does hereby certify as follows: FIRST. The Corporation filed its original certificate of incorporation with the Sec
April 14, 2022	EX-3.2	Amended and Restated Bylaws of IQVIA Holdings Inc., effective April 12, 2022 Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF IQVIA HOLDINGS INC. SECTION 1 - STOCKHOLDERS Section 1.1. Annual Meeting. An annual meeting of the stockholders of IQVIA Holdings Inc., a Delaware corporation (the ?Corporation?), for the election of directors to succeed those whose terms expire and for the transaction of such other business as may properly come before the meeting shall be held at the pla
April 14, 2022	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 14, 2022 (April 12, 2022) IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation)
March 28, 2022	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin
March 14, 2022	EX-99.1	IQVIA Appoints Costa Panagos President of Research & Development Solutions (R&DS) Exhibit 99.1 NEWS Contact: Nick Childs, IQVIA Investor Relations ([email protected]) +1.973.316.3828 Tor Constantino, IQVIA Media Relations ([email protected]) +1.484.567.6732 IQVIA Appoints Costa Panagos President of Research & Development Solutions (R&DS) RESEARCH TRIANGLE PARK, N.C. ? March 14, 2022 ? IQVIA Holdings Inc. (?IQVIA?) (NYSE:IQV), a leading global provider of advanced an
March 14, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 14, 2022 (March 10, 2022) IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation)
February 28, 2022	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin
February 28, 2022	DEF 14A	NOTICE Table of Contents Proxy Statement Summary PROPOSAL NO. 1 Election of Directors PROPOSAL NO. 2 Amendment to Certificate of Incorporation to Declassify the Board Corporate Governance Director Compensation PROPOSAL NO. 3 Non-Binding Vote on Execu UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin
February 18, 2022	PRE 14A	NOTICE Table of Contents Proxy Statement Summary PROPOSAL NO. 1 Election of Directors PROPOSAL NO. 2 Amendment to Certificate of Incorporation to Declassify the Board Corporate Governance Director Compensation PROPOSAL NO. 3 Non-Binding Vote on Execu UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin
February 16, 2022	EX-21.1	List of Subsidiaries of IQVIA Holdings Inc. Exhibit 21.1 IQVIA Holdings Inc. Subsidiary Listing ? as of 12/31/2021 Subsidiary Jurisdiction or State of Organization 159 Solutions, LLC California 159 Technology Solutions Private Ltd India AECIO IT Solutions India Private Ltd. India AHM Global Services, LLC New Jersey Albatross Financial Solutions Limited England ALIMED Egeszsegugyi Szolgaltato Kft. Hungary Allcare Plus Pharmacy LLC Massachuse
February 16, 2022	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-35907 IQVIA HOLDIN
February 15, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 15, 2022 IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation) (Commission F
February 15, 2022	EX-99.1	IQVIA Reports Fourth-Quarter and Full-Year 2021 Results; Raises Full-Year 2022 Profit Guidance Exhibit 99.1 IQVIA Reports Fourth-Quarter and Full-Year 2021 Results; Raises Full-Year 2022 Profit Guidance Revenue of $3,636 million for the fourth quarter grew 10.2 percent year-over-year on a reported basis and 11.6 percent at constant currency GAAP Net Income of $318 million for the fourth quarter grew 167.2 percent year-over-year Adjusted EBITDA of $828 million for the fourth quarter grew 12.
February 10, 2022	SC 13G/A	IQV / Iqvia Holdings Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 8)* Name of issuer: IQVIA Holdings Inc. Title of Class of Securities: Common Stock CUSIP Number: 46266C105 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒
January 27, 2022	EX-99.2	Sheila A. Stamps Joins IQVIA Board of Directors Exhibit 99.2 News Release Contacts: Nick Childs, IQVIA Investor Relations ([email protected]) +1.973.316.3828 Tor Constantino, IQVIA Media Relations ([email protected]) +1.484.567.6732 Sheila A. Stamps Joins IQVIA Board of Directors RESEARCH TRIANGLE PARK, N.C ? January 26, 2022 ? IQVIA (NYSE:IQV) today announced the appointment of Sheila A. Stamps to its board of directors, effective
January 27, 2022	8-K	Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 26, 2022 (January 24, 2022) IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporat
January 27, 2022	EX-99.1	Leslie Wims Morris Joins IQVIA Board of Directors Exhibit 99.1 News Release Contacts: Nick Childs, IQVIA Investor Relations ([email protected]) +1.973.316.3828 Tor Constantino, IQVIA Media Relations ([email protected]) +1.484.567.6732 Leslie Wims Morris Joins IQVIA Board of Directors RESEARCH TRIANGLE PARK, N.C. ? January 24, 2022 ? IQVIA (NYSE:IQV), a global provider of advanced analytics, technology solutions, and clinical research
October 22, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-35907 IQV
October 21, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 21, 2021 IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation) (Commission Fi
October 21, 2021	EX-99.1	IQVIA Reports Third-Quarter 2021 Results and Raises Full-Year 2021 Guidance Exhibit 99.1 IQVIA Reports Third-Quarter 2021 Results and Raises Full-Year 2021 Guidance Revenue of $3,391 million for the third quarter grew 21.7 percent year-over-year GAAP Net Income of $261 million for the third quarter grew 158.4 percent year-over-year Adjusted EBITDA of $728 million for the third quarter grew 20.5 percent year-over-year GAAP Diluted Earnings per Share of $1.34 for the third
August 25, 2021	EX-10.1	Amendment No. 9, dated August 25, 2021, to Fourth Amended and Restated Credit Agreement, dated October 3, 2016, among IQVIA Inc., IQVIA Holdings Inc., IQVIA RDS Inc., IQVIA AG, IQVIA Solutions Japan K.K., the other guarantors party thereto, Bank of America, N.A. as administrative agent and as collateral agent, and the Lenders party thereto. Exhibit 10.1 AMENDMENT NO. 9 TO FOURTH AMENDED AND RESTATED CREDIT AGREEMENT, AMENDMENT NO. 1 TO AMENDED AND RESTATED PLEDGE AND SECURITY AGREEMENT AND AMENDMENT NO. 1 TO U.S. GUARANTY AMENDMENT NO. 9, dated as of August 25, 2021 (this ?Amendment?), among IQVIA Inc., a Delaware corporation (the ?Parent Borrower?), IQVIA RDS Inc., a North Carolina corporation and a subsidiary of the Parent Borrower
August 25, 2021	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 25, 2021 IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation) (Commission Fil
July 28, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-35907 IQVIA HO
July 27, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 27, 2021 IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation) (Commission File
July 27, 2021	EX-99.1	IQVIA Reports Second-Quarter 2021 Results and Raises Full-Year 2021 Guidance Exhibit 99.1 IQVIA Reports Second-Quarter 2021 Results and Raises Full-Year 2021 Guidance Revenue of $3,438 million for the second quarter grew 36.4 percent year-over-year GAAP Net Income of $175 million for the second quarter increased from $(23) million in 2020 Adjusted EBITDA of $722 million for the second quarter increased from $483 million in 2020 GAAP Diluted Earnings per Share of $0.90 for
April 23, 2021	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-35907 IQVIA H
April 22, 2021	EX-99.1	IQVIA Reports First-Quarter Results; Raises Full-Year 2021 Guidance Exhibit 99.1 IQVIA Reports First-Quarter Results; Raises Full-Year 2021 Guidance Revenue of $3,409 million for the first quarter grew 23.8 percent year-over-year Adjusted EBITDA of $744 million for the first quarter increased 32.4 percent year-over-year GAAP Diluted Earnings per Share of $1.09 for the first quarter; Adjusted Diluted Earnings per Share of $2.18 for the first quarter grew 45.3 perce
April 22, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 22, 2021 IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation) (Commission File
April 16, 2021	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 16, 2021 (April 13, 2021) IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation)
April 16, 2021	EX-3.1	Amended and Restated Certificate of Incorporation of IQVIA Holdings Inc., effective April 13, 2021 Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF IQVIA HOLDINGS INC. (Under Sections 242 and 245 of the Delaware General Corporation Law) IQVIA Holdings Inc., a corporation organized and existing under the laws of the State of Delaware, as amended (the ?Corporation?), does hereby certify as follows: FIRST. The Corporation filed its original certificate of incorporation with the Sec
April 1, 2021	EX-99.1	IQVIA Acquires Remaining Interest in Q2 Solutions from Quest Raises Full Year 2021 Adjusted Diluted EPS Guidance EX-99.1 Exhibit 99.1 Contacts: Andrew Markwick, IQVIA Investor Relations ([email protected]) +1.973.257.7144 Tor Constantino, IQVIA Media Relations ([email protected]) +1.484.567.6732 IQVIA Acquires Remaining Interest in Q2 Solutions from Quest Diagnostics Raises Full Year 2021 Adjusted Diluted EPS Guidance DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C. April 1, 2021 – IQVIA Holding
April 1, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 1, 2021 IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation) (Commission File
March 23, 2021	DEFA14A	- DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin
March 9, 2021	PX14A6G	- IQVIA Holdings Inc. (IQV) Shareholder Alert Voluntary submission by John Chevedden, POB 2673, Redondo Beach, CA 90278. Important Information on Proposal No. 3: Amendments to Certificate of Incorporation to Remove Supermajority Voting Standards Management omitted to mention that a rule 14a-8 shareholder proposal was submitted on the same topic as this management Proposal 3 in October 2020. Thus arg
March 3, 2021	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 3, 2021 IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation) (Commission File
March 3, 2021	EX-4.1	Indenture, dated March 3, 2021, among IQVIA Inc., as Issuer, U.S. Bank National Exhibit 4.1 INDENTURE Dated as of March 3, 2021 among IQVIA Inc., as Issuer, the Guarantors party hereto and U.S. Bank National Association, as Trustee 1.750% SENIOR NOTES DUE 2026 2.250% SENIOR NOTES DUE 2029 Table of Contents Page ARTICLE I DEFINITIONS AND INCORPORATION BY REFERENCE SECTION 1.01. Definitions. 1 SECTION 1.02. Other Definitions. 33 SECTION 1.03. Rules of Construction 34 SECTION 1.
February 26, 2021	DEFA14A	- DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin
February 26, 2021	DEF 14A	- DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for use of the Commission Only (as permitted by Rule 14
February 17, 2021	EX-99.1	IQVIA Announces Pricing of Offering of Senior Notes Exhibit 99.1 News Release IQVIA Announces Pricing of Offering of Senior Notes February 17, 2021 DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C. ? IQVIA Holdings Inc. (?IQVIA?) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the ?Issuer?), priced an offering of ?1,450,000,000 in aggregate principal amount of senior notes, consisting of ?550,000,000 in aggregate principal amou
February 17, 2021	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 17, 2021 IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation) (Commission F
February 16, 2021	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 16, 2021 IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 001-35907 27-1341991 (State or other jurisdiction of incorporation) (Commission F
February 16, 2021	PRE 14A	- PRE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin
February 16, 2021	EX-99.1	IQVIA Announces Offering of Senior Notes EX-99.1 Exhibit 99.1 News Release IQVIA Announces Offering of Senior Notes February 16, 2021 DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C. – IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), intends to raise €1,450,000,000 in gross proceeds (equivalent to approximately $1,761,000,000) through an offering of senior notes due 2026 a
February 12, 2021	EX-21.1	List of Subsidiaries of IQVIA Holdings Inc. Exhibit 21.1 IQVIA Holdings Inc. Subsidiary Listing ? as of 12/31/2020 Subsidiary Jurisdiction or State of Organization 159 Solutions, LLC California 159 Technology Solutions Private Ltd India Advanced Health Media Services Ltd. United Kingdom AECIO IT Solutions India Private Ltd. India Albatross Financial Solutions Limited United Kingdom ALIMED Egeszsegugyi Szolgaltato Kft. Hungary Allcare Plus P
February 12, 2021	10-K	Annual Report - 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-35907 IQVIA HOLDIN
February 10, 2021	SC 13G/A	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 7)* SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 7)* Name of issuer: IQVIA Holdings Inc. Title of Class of Securities: Common Stock CUSIP Number: 46266C105 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒

MX:IQV
IT:1IQV	€ 167.00
DE:QTS	€ 160.30
GB:0JDM
AT:IQVH

IQV / IQVIA Holdings Inc. - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

Mga Batayang Estadistika

SEC Filings

SEC Filings (Chronological Order)

Other Listings